Label: Information for the User
Exforge 5mg/80mg film-coated tablets
Exforge 5mg/160mg film-coated tablets
Exforge 10mg/160mg film-coated tablets
amlodipino/valsartán
Read this label carefully before starting to take this medication, as it contains important information for you.
-This medication has been prescribed only for you, and you should not give it to others even if they have the same symptoms of disease as you, as it may harm them.
-If you experience any adverse effects, consult your doctor or pharmacist, even if they are not listed in this label.See section4.
1.What Exforge is and for what it is used
2.What you need to know before starting to take Exforge
3.How to take Exforge
4.Possible adverse effects
5.Storage of Exforge
6.Contents of the package and additional information
Exforge tablets contain two substances called amlodipine and valsartan. Both substances help control high blood pressure.
This means that both substances help prevent blood vessel constriction. As a result, blood vessels relax and blood pressure decreases.
Exforge is used to treat high blood pressure in adults whose blood pressure is not adequately controlled with amlodipine or valsartan alone.
Do not take Exforge
Do not take Exforge and inform your doctorif you are affected by any of the above cases.
Warnings and precautions
Consult your doctor before starting to take Exforge:
Your doctor may monitor your kidney function, blood pressure, and electrolyte levels (such as potassium) at regular intervals.
See also the information under the heading “Do not take Exforge”.
Inform your doctor before taking Exforge if you are affected by any of the cases mentioned.
Children and adolescents
Exforge is not recommended for use in children or adolescents (under 18 years old).
Other medications and Exforge
Inform your doctor or pharmacist if you are using, have used recently, or may need to use any other medication. Your doctor may need to adjust your dose and/or take other precautions. In some cases, you may need to stop taking one of the medications. This applies especially to the medications listed below:
allowing it to accept the transplanted organ);
Taking Exforge with food and drinks
People taking Exforge should not consume grapefruit or grapefruit juice. This is because grapefruit and grapefruit juice may cause an increase in the blood levels of the active ingredient amlodipine, which may lead to unpredictable reductions in Exforge's blood pressure-lowering effects.
Pregnancy and breastfeeding
Pregnancy
You should inform your doctor if you are pregnant, if you suspect you may be pregnant, or if you plan to become pregnant.
Breastfeeding
Inform your doctor if you are planning to start or are currently breastfeeding.Amlodipine has been shown to pass into breast milk in small amounts.Exforge is not recommended for use during this period. Your doctor may decide to administer a more suitable treatment if you want to breastfeed, especially for newborns or premature babies.
Consult your doctor or pharmacist before using any medication.
Driving and operating machinery
This medication may cause dizziness, which may affect your ability to concentrate. Therefore, if you are unsure how this medication will affect you, do not drive, operate machinery, or perform other activities that require concentration.
Follow exactly the administration instructions for this medication as indicated by your doctor. If in doubt, consult your doctor again. This will help you achieve the best results and reduce the risk of adverse effects.
The usual dose of Exforge is one tablet per day.
Your doctor may suggest a higher or lower dose depending on your response to treatment.
Do not exceed the prescribed dose.
Exforge and Older Adults (65 years or older)
Your doctor should exercise caution when increasing the dose.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
If You Take Too Much Exforge
If you have taken too many Exforge tablets, or if someone else has taken your tablets, consult a doctor immediately.Excess fluid may accumulate in the lungs (pulmonary edema) causing difficulty breathing that may develop within 24-48 hours after ingestion.
If You Forget to Take Exforge
If you forget to take this medication, take it as soon as you remember. Then take the next dose at the usual time. However, if it is almost time for the next dose, do not take the missed dose. Do not take a double dose to make up for the missed doses.
If You Stop Taking Exforge
Stopping your treatment with Exforge may cause your condition to worsen. Do not stop taking your medication unless your doctor tells you to.
Like all medicines, Exforge can cause side effects, although not everyone will experience them.
Some side effects can be serious and require immediate medical attention:
A few patients have experienced these severe side effects.Notify your doctor immediately if you notice any of the following:
Rare(may affect up to 1 in 1,000 patients):Allergic reaction with symptoms such as skin rash, itching, facial swelling, lip or tongue swelling, difficulty breathing, low blood pressure (dizziness, fainting).
Very rare (may affect up to 1 in 10,000 patients):Intestinal angioedema: swelling in the intestine accompanied by symptoms such as abdominal pain, nausea, vomiting, and diarrhea.
Other possible side effects of Exforge:
Frequent(may affect up to 1 in 10 patients):Flu; stuffy nose, sore throat, and discomfort swallowing; headache; swelling in the arms, hands, legs, ankles, or feet; fatigue; asthenia (weakness); flushing and warming of the face and/or neck.
Occasional(may affect up to 1 in 100 patients):Dizziness; nausea and abdominal pain; dry mouth; drowsiness, tingling, or numbness in the hands or feet; vertigo, rapid heart rate including palpitations; dizziness upon standing; cough; diarrhea; constipation; skin rash, redness of the skin; joint inflammation, back pain; joint pain.
Rare(may affect up to 1 in 1,000 patients):Anxiety; tinnitus (ringing in the ears); fainting; increased urine production or urgent need to urinate; inability to achieve or maintain an erection; feeling of heaviness; low blood pressure with symptoms such as dizziness, fainting; excessive sweating; skin rash all over the body, itching, muscle spasms.
Notify your doctor if any of the mentioned cases severely affect you.
Side effects reported with amlodipine or valsartan alone and not observed with Exforge or observed with a higher frequency than with Exforge:
Amlodipine
Consult your doctor immediately if you experience any of the following severe side effects, which are very rare after taking this medication:
The following side effects have been reported. If any of these cause problems or last more than a week, consult your doctor.
Frequent(may affect up to 1 in 10 patients):Dizziness, drowsiness; palpitations (feeling the heartbeat); hot flashes, swelling of the ankles (edema); abdominal pain, feeling unwell (nausea).
Occasional(may affect up to 1 in 100 patients):Mood changes, anxiety, depression, drowsiness, tremors, altered taste, fainting, loss of sensation of pain; visual disturbances, visual deterioration, ringing in the ears; decreased blood pressure; nasal congestion and secretion caused by inflammation of the nasal mucosa (rhinitis); indigestion, vomiting (discomfort); hair loss, increased sweating, itching skin, skin discoloration; urinary disorders, increased need to urinate at night, increased frequency of urination; inability to achieve an erection, discomfort or enlargement of the breasts in men, pain, feeling unwell, muscle pain, muscle cramps; weight gain or loss.
Rare(may affect up to 1 in 1,000 patients):Confusion.
Very rare(may affect up to 1 in 10,000 patients):Decreased white blood cell count, decreased platelet count that can cause easy bleeding or unusual bruising (damage to red blood cells); high blood sugar (hyperglycemia); inflammation of the gums, abdominal swelling (gastritis); abnormal liver function, inflammation of the liver (hepatitis), yellowing of the skin (jaundice), increased liver enzymes that can affect some medical tests; muscle tension; inflammation of blood vessels often with skin eruptions, light sensitivity; disorders combining stiffness, tremors, and/or movement disorders.
Valsartan
Unknown frequency (frequency cannot be estimated from available data):Decreased red blood cell count, fever, sore throat or ulcers in the mouth due to infection; spontaneous bleeding or skin hematomas; increased potassium in the blood; abnormal liver function test results; decreased kidney function and severely decreased kidney function; swelling, mainly of the face and throat; muscle pain; skin rash, red purpura spots; fever; itching; allergic reaction, blistering skin disease (sign of a disease called dermatitis bullosa).
Notify your doctor immediately if you experience any of the mentioned cases.
If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this prospectus.
Reporting side effects
If you experienceany type of side effect, consult your doctor or pharmacist, even if it is apossibleside effect not listed in this prospectus.You can also report them directlythrough the national notification system included in theAnexo V. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the box and the blister pack.
Do not store above30°C.
Store in the original packaging to protect it from moisture.
Do not use Exforge if you observe that the packaging is damaged or shows signs of tampering.
Composition ofExforge
Exforge 5mg/80mg film-coated tablets
The active ingredients of Exforge are amlodipine (as amlodipine besylate) and valsartan. Each tablet contains 5mg of amlodipine and 80mg of valsartan.
The other components are microcrystalline cellulose; crospovidone (type A); anhydrous colloidal silica; magnesium stearate; hypromellose (type of substitution 2910 (3 mPa.s)); macrogol 4000; talc, titanium dioxide (E171); yellow iron oxide (E172).
Exforge 5mg/160mg film-coated tablets
The active ingredients of Exforge are amlodipine (as amlodipine besylate) and valsartan. Each tablet contains 5mg of amlodipine and 160mg of valsartan.
The other components are microcrystalline cellulose, crospovidone (type A); anhydrous colloidal silica; magnesium stearate; hypromellose (type of substitution 2910 (3 mPa.s)); macrogol 4000; talc, titanium dioxide (E171); yellow iron oxide (E172).
Exforge 10mg/160mg film-coated tablets
The active ingredients of Exforge are amlodipine (as amlodipine besylate) and valsartan. Each tablet contains 10mg of amlodipine and 160mg of valsartan.
The other components are microcrystalline cellulose, crospovidone (type A), anhydrous colloidal silica; magnesium stearate; hypromellose (type of substitution 2910 (3 mPa.s)); macrogol 4000; talc, titanium dioxide (E171); yellow iron oxide (E172), red iron oxide (E172).
Appearance of the product and contents of the pack
Exforge 5mg/80mg tablets are round and brown-yellow in color with«NVR»on one side and«NV»on the other side.Approximate size: diameter 8.20mm.
Exforge 5mg/160mg tablets are oval and brown-yellow in color with«NVR»on one side and«ECE»on the other side.Approximate size:14.2mm (length) x 5.7mm (width).
Exforge 10mg/160mg tablets are oval and light yellow in color with«NVR»on one side and«UIC»on the other side.Approximate size:14.2mm (length) x 5.7mm (width).
Exforge is available in packs containing 7, 14, 28, 30, 56, 90, 98 or 280tabletsand in multiple packs containing 4boxes, each containing 70tablets, or 20boxes, each containing 14tablets.All packs are available with standard blisters; packs of 56, 98 and 280tablets are also available with perforated unit dose blisters.
Not all pack sizes may be marketed in your country.
Marketing Authorisation Holder
Novartis Europharm Limited
Vista Building
Elm Park, Merrion Road
Dublin 4
Irlanda
Responsible for manufacturing
Novartis Farma S.p.A.
Via Proviniciale Schito 131
80058 Torre Annunziata (NA)
Italia
Novartis Farmacéutica SA
Gran Via de les Corts Catalanes, 764
08013 Barcelona
España
Novartis Pharma GmbH
Roonstraße 25
D-90429 Nuremberg
Alemania
Novartis Pharma GmbH
Sophie-Germain-Strasse 10
90443 Nürnberg
Alemania
For further information about this medicinal product, please contact the local representative of the marketing authorisation holder:
België/Belgique/Belgien Novartis Pharma N.V. Tél/Tel: +32 2 246 16 11 | Lietuva SIA „Novartis Baltics“ Lietuvos filialas Tel: +370 5 269 16 50 |
Luxembourg/Luxemburg Novartis Pharma N.V. Tél/Tel: +32 2 246 16 11 | |
Ceská republika Novartiss.r.o. Tel: +420 225 775 111 | Magyarország Novartis Hungária Kft. Tel.: +36 1 457 65 00 |
Danmark Novartis Healthcare A/S Tlf: +45 39 16 84 00 | Malta Novartis Pharma Services Inc. Tel:+356 2122 2872 |
Deutschland Novartis Pharma GmbH Tel: +49 911 273 0 | Nederland Novartis Pharma B.V. Tel: +31 26 37 82 111 |
Eesti SIA Novartis Baltics Eesti filiaal Tel:+372 66 30 810 | Norge Novartis Norge AS Tlf: +47 23 05 20 00 |
Ελλ?δα Novartis (Hellas) A.E.B.E. Τηλ: +30 210 281 17 12 | Österreich Novartis Pharma GmbH Tel: +43 1 86 6570 |
España Novartis Farmacéutica, S.A. Tel: +34 93 306 42 00 | Polska Novartis Poland Sp. z o.o. Tel.:+48 22 375 4888 |
France Novartis Pharma S.A.S. Tél: +33 1 55 47 66 00 | Portugal Novartis Farma - Produtos Farmacêuticos, S.A. Tel: +351 21 000 8600 |
Hrvatska Novartis Hrvatska d.o.o. Tel. +385 1 6274 220 | România Novartis Pharma ServicesRomania SRL Tel: +40 21 31299 01 |
Ireland Novartis Ireland Limited Tel: +353 1 260 12 55 | Slovenija Novartis Pharma Services Inc. Tel: +386 1 300 75 50 |
Ísland Vistor hf. Sími: +354 535 7000 | Slovenská republika Novartis Slovakia s.r.o. Tel: +421 2 5542 5439 |
Italia Novartis Farma S.p.A. Tel: +39 02 96 54 1 | Suomi/Finland Novartis Finland Oy Puh/Tel:+358 (0)10 6133 200 |
Κ?προς Novartis Pharma Services Inc. Τηλ: +357 22 690 690 | Sverige Novartis Sverige AB Tel: +46 8 732 32 00 |
Latvija SIA “Novartis Baltics” Tel: +371 67 887 070 |
Last update of this leaflet:
Other sources of information
The detailed information on this medicinal product is available on the website of the European Medicines Agency:http://www.ema.europa.eu
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.